Is Quanterix Corporation (QTRX) a Buy, Sell, or Hold?
NASDAQ : QTRX
Quanterix Corporation — Institutional Ownership
$2.42 USD
-$1.61 (-39.95%)
- Volume
- 4M
- Average Volume
- 1.03M
- Market Capitalization
- $114M
- P/E Ratio
- -0.92
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $8.77
- Year Low
- $2.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.40
Institutional Ownership Summary
Institutional Ownership %
18.03%
Investors Holding
49
change: -80.0 | last: 129
Increased Positions
31
change: -39.0 | last: 70
Reduced Positions
6
change: -30.0 | last: 36
New Positions
16
change: -3.0 | last: 19
Sold Positions
94
change: 68.0 | last: 26
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: 0.0 | last: 0
Total Invested
36.58M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Ameriprise Financial, Inc. | 3.54M | 7.50% |
| 2026-05-15 | Portolan Capital Management, LLC | 2.95M | 6.25% |
| 2026-05-07 | Ameriprise Financial, Inc. | 990.22K | 2.10% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Ameriprise Financial, Inc. | 5M | 10.70% |
| 2025-11-19 | Telegraph Hill Partners III, L.P. | 2.5M | 5.40% |
| 2025-11-14 | Ameriprise Financial, Inc. | 4.24M | 9.10% |
| 2025-08-13 | Portolan Capital Management, LLC | 3.63M | 9.36% |
| 2025-07-17 | BlackRock, Inc. | 2.84M | 7.30% |
| 2025-07-15 | Kent Lake Partners LP | 2.09M | 4.50% |
| 2025-05-15 | Ameriprise Financial, Inc. | 3.72M | 9.60% |
| 2025-05-15 | Portolan Capital Management, LLC | 2.96M | 7.64% |
| 2025-05-14 | AllianceBernstein L.P. | 36980.0 | 0.10% |
| 2025-05-07 | Ameriprise Financial, Inc. | 4.16M | 10.70% |
| 2025-04-30 | Quanterix Corporation | 30.56M | 55.60% |
| 2025-04-30 | Akoya Biosciences, Inc. | - | 0.00% |
| 2025-04-30 | The Vanguard Group | 2.53M | 6.51% |
| 2025-04-23 | Integrated Core Strategies (US) LLC | - | 0.00% |
| 2025-03-03 | Kent Lake Partners LP | 2.65M | 6.90% |
| 2025-02-14 | Ameriprise Financial, Inc. | 3.21M | 8.30% |
| 2025-02-13 | Kent Lake Partners LP | 2.28M | 5.91% |
| 2025-02-05 | AllianceBernstein L.P. | 2.44M | 6.30% |
| 2025-01-16 | Akoya Biosciences, Inc. | 2.96M | 6.20% |
| 2025-01-16 | Quanterix Corporation | 27.71M | 55.90% |
| 2024-06-27 | Portolan Capital Management, LLC | 1.92M | 5.01% |
| 2024-06-27 | George McCabe | 1.92M | 5.01% |
| 2024-06-27 | Portolan Capital Management, LLC | 1.92M | 5.01% |
| 2024-06-27 | George McCabe | 1.92M | 5.01% |
| 2024-02-13 | The Vanguard Group - 23-1945930 | 2.06M | 5.43% |
| 2023-09-29 | Millennium Group Management LLC | 1.99M | 5.30% |
| 2023-09-29 | Israel A. Englander | 1.99M | 5.30% |
| 2023-09-29 | Millennium Management LLC | 1.99M | 5.30% |
| 2023-09-29 | Millennium Group Management LLC | 1.99M | 5.30% |
| 2023-09-29 | Israel A. Englander | 1.99M | 5.30% |
| 2023-09-29 | Millennium Management LLC | 1.99M | 5.30% |
| 2022-02-14 | Gagnon, Howe & Co. LLC | 2.84M | 7.70% |
| 2022-02-14 | Gagnon, Howe & Co. LLC | 2.84M | 7.70% |
| 2022-02-11 | 10. | 6817.0 | 0.02% |
| 2022-02-11 | 10. | 3.1M | 8.46% |
| 2022-02-11 | 10. | 371.0 | 0.00% |
| 2022-02-11 | 10. | 48304.0 | 0.13% |
| 2022-02-11 | 10. | 3.15M | 8.61% |
| 2022-02-11 | 10. | 3.15M | 8.61% |
| 2022-02-11 | 10. | 48304.0 | 0.13% |
| 2022-02-11 | 10. | 3.1M | 8.46% |
| 2022-02-11 | 10. | 371.0 | 0.00% |
| 2022-02-11 | 10. | 3.1M | 8.46% |
| 2022-02-11 | 10. | 6817.0 | 0.02% |
| 2022-02-11 | 10. | 2.44M | 6.66% |
| 2022-02-11 | 10. | 2.44M | 6.66% |
| 2022-02-11 | 10. | 3.1M | 8.46% |
| 2022-02-04 | (1) BlackRock, Inc. | 2.46M | 6.70% |
| 2021-03-10 | (1) BlackRock, Inc. | 1.74M | 4.90% |
| 2021-02-16 | Gilder, Gagnon, Howe & Co. LLC | 3.08M | 9.71% |
| 2021-02-16 | Gilder, Gagnon, Howe & Co. LLC | 3.08M | 9.71% |
| 2021-02-02 | (1) BlackRock, Inc. | 1.74M | 5.50% |
| 2021-02-02 | ARCH Venture Fund VI, L.P. | 3.12M | 9.90% |
| 2020-02-14 | LLC | 3.35M | 11.94% |
| 2020-02-14 | LLC | 3.35M | 11.94% |
| 2020-02-14 | 52-0556948 | 1.44M | 5.20% |
| 2020-02-14 | 52-0556948 | 1.44M | 5.20% |
| 2019-06-10 | Gilder, Gagnon, Howe & Co. LLC | 3.07M | 13.60% |
| 2019-06-10 | Gilder, Gagnon, Howe & Co. LLC | 3.07M | 13.60% |
| 2018-02-14 | Cloverdale Capital GP, L.P. | 950.36K | 3.50% |
| 2018-02-14 | bioMérieux SA | 2.06M | 9.40% |
| 2018-02-13 | Abigail P. Johnson | 1.2M | 5.52% |
| 2018-02-13 | FMR LLC | 1.2M | 5.52% |
| 2018-02-02 | ARCH Venture Partners VIII, LLC | 3.95M | 18.10% |
| 2018-02-02 | ARCH Venture Fund VIII Overage, L.P. | 3.95M | 18.10% |
| 2018-02-02 | ARCH Venture Partners VI, LLC | 3.95M | 18.10% |
| 2018-02-02 | ARCH Venture Fund VI, L.P. | 3.95M | 18.10% |
| 2018-02-02 | Robert Nelsen | 3.95M | 18.10% |
| 2018-02-02 | ARCH Venture Partners VIII, LLC | 3.95M | 18.10% |
| 2018-02-02 | ARCH Venture Partners VI, LLC | 3.95M | 18.10% |
| 2018-02-02 | ARCH Venture Partners VI, L.P. | 3.95M | 18.10% |
| 2018-02-02 | ARCH Venture Fund VIII Overage, L.P. | 3.95M | 18.10% |
| 2018-02-02 | Robert Nelsen | 3.95M | 18.10% |
| 2018-02-02 | Clinton Bybee | 3.95M | 18.10% |
| 2018-02-02 | Keith Crandell | 3.95M | 18.10% |
| 2018-02-02 | ARCH Venture Partners VI, L.P. | 3.95M | 18.10% |
| 2018-02-02 | Keith Crandell | 3.95M | 18.10% |
| 2018-02-02 | Clinton Bybee | 3.95M | 18.10% |
| 2018-02-02 | ARCH Venture Fund VI, L.P. | 3.95M | 18.10% |
QTRX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6.36 | 42.64M | $271.18M | $29.84M | $37.24M | $278.58M |
| 2024-12-31 | $10.63 | 38.37M | $407.84M | $56.71M | $37.37M | $388.5M |
| 2023-12-31 | $27.34 | 37.59M | $1.03B | $174.42M | $41.46M | $894.86M |
| 2022-12-31 | $13.85 | 36.99M | $512.32M | $338.74M | $44.1M | $217.69M |
| 2021-12-31 | $42.40 | 36M | $1.53B | $396.46M | $21.89M | $1.15B |
| 2020-12-31 | $46.50 | 29.59M | $1.38B | $181.58M | $30.8M | $1.23B |
| 2019-12-31 | $23.63 | 25.09M | $592.89M | $109.16M | $7.66M | $491.4M |
| 2018-12-31 | $18.31 | 21.99M | $402.72M | $45.43M | $7.62M | $364.91M |
| 2017-12-31 | $21.47 | 21.71M | $466.05M | $79.68M | $9.38M | $395.75M |
| 2016-12-31 | $17.47 | 16.21M | $283.13M | $29.67M | $10.24M | $263.71M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4.32 | 46.98M | $202.95M | $44.17M | $33.39M | $192.17M |
| 2026-03-31 | $3.52 | 46.98M | $165.37M | $36.18M | $35.34M | $164.52M |
| 2025-12-31 | $6.36 | 46.78M | $297.52M | $29.84M | $37.24M | $304.92M |
| 2025-09-30 | $5.43 | 46.06M | $250.11M | $38.3M | $40.12M | $251.93M |
| 2025-06-30 | $6.65 | 38.89M | $258.64M | $132.9M | $35.53M | $161.28M |
| 2025-03-31 | $6.51 | 38.72M | $252.05M | $76.51M | $36.41M | $211.95M |
| 2024-12-31 | $10.63 | 38.55M | $409.8M | $56.71M | $37.37M | $390.46M |
| 2024-09-30 | $12.96 | 38.45M | $498.3M | $29.34M | $38.49M | $507.45M |
| 2024-06-30 | $12.68 | 38.34M | $486.13M | $47M | $39.58M | $478.7M |
| 2024-03-31 | $23.78 | 38.13M | $906.64M | $45.28M | $40.45M | $901.81M |
| 2023-12-31 | $27.34 | 37.89M | $1.04B | $174.42M | $41.46M | $902.95M |
| 2023-09-30 | $27.14 | 37.66M | $1.02B | $201.26M | $42.4M | $863.15M |